News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
845,154 Results
Type
Article (86418)
Company Profile (702)
Press Release (758034)
Multimedia
Podcasts (128)
Webinars (14)
Section
Business (232641)
Career Advice (4126)
Deals (39715)
Drug Delivery (129)
Drug Development (90969)
Employer Resources (198)
FDA (18094)
Job Trends (17328)
News (396388)
Policy (39736)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (91)
Alliances (56808)
ALS (97)
Alzheimer's disease (1496)
Antibody-drug conjugate (ADC) (152)
Approvals (18057)
Artificial intelligence (315)
Autoimmune disease (29)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (481)
Bladder cancer (70)
Brain cancer (31)
Breast cancer (295)
Cancer (2309)
Cardiovascular disease (198)
Career advice (3532)
Career pathing (34)
CAR-T (166)
Cell therapy (471)
Cervical cancer (21)
Clinical research (73297)
Collaboration (887)
Compensation (537)
Complete response letters (30)
COVID-19 (2862)
CRISPR (45)
C-suite (254)
Cystic fibrosis (107)
Data (2150)
Decentralized trials (2)
Denatured (45)
Depression (54)
Diabetes (290)
Diagnostics (6906)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (151)
Drug pricing (125)
Drug shortages (33)
Duchenne muscular dystrophy (99)
Earnings (96417)
Editorial (43)
Employer branding (25)
Employer resources (167)
Events (129611)
Executive appointments (752)
FDA (19373)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (798)
Gene editing (115)
Generative AI (35)
Gene therapy (340)
GLP-1 (847)
Government (5153)
Grass and pollen (6)
Guidances (51)
Healthcare (20883)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (141)
Indications (29)
Infectious disease (3021)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (97)
Interviews (812)
IPO (17806)
IRA (51)
Job creations (5186)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (549)
Leadership (22)
Legal (10112)
Liver cancer (78)
Lung cancer (332)
Lymphoma (151)
Machine learning (5)
Management (65)
Manufacturing (340)
MASH (72)
Medical device (14612)
Medtech (14617)
Mergers & acquisitions (22430)
Metabolic disorders (772)
Multiple sclerosis (84)
NASH (23)
Neurodegenerative disease (108)
Neuropsychiatric disorders (33)
Neuroscience (2078)
NextGen: Class of 2025 (7682)
Non-profit (5077)
Northern California (2641)
Now hiring (40)
Obesity (419)
Opinion (274)
Ovarian cancer (76)
Pain (93)
Pancreatic cancer (83)
Parkinson's disease (158)
Partnered (24)
Patents (244)
Patient recruitment (108)
Peanut (51)
People (65237)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22607)
Phase II (31818)
Phase III (23991)
Pipeline (1182)
Policy (165)
Postmarket research (3552)
Preclinical (10158)
Press Release (72)
Prostate cancer (105)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (423)
Real estate (7391)
Recruiting (75)
Regulatory (26736)
Reports (57)
Research institute (2657)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (50)
Schizophrenia (78)
Series A (139)
Series B (87)
Service/supplier (30)
Sickle cell disease (58)
Southern California (2290)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4288)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (35)
The Weekly (81)
United States (23937)
Vaccines (796)
Venture capitalists (44)
Weight loss (301)
Women's health (40)
Worklife (19)
Date
Today (152)
Last 7 days (582)
Last 30 days (2650)
Last 365 days (35916)
2025 (10693)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (59)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (50075)
Australia (8824)
California (6176)
Canada (2005)
China (539)
Colorado (276)
Connecticut (293)
Delaware (150)
Europe (114805)
Florida (899)
Georgia (216)
Hawaii (1)
Idaho (64)
Illinois (611)
India (30)
Indiana (330)
Iowa (11)
Japan (161)
Kansas (109)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (942)
Massachusetts (4756)
Michigan (243)
Minnesota (413)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (62)
New Hampshire (69)
New Jersey (1764)
New Mexico (31)
New York (1759)
North Carolina (1108)
North Dakota (8)
Northern California (2641)
Ohio (214)
Oklahoma (15)
Oregon (47)
Pennsylvania (1368)
Puerto Rico (12)
Rhode Island (35)
South America (1652)
South Carolina (22)
South Dakota (1)
Southern California (2290)
Tennessee (103)
Texas (934)
Utah (184)
Virginia (166)
Washington D.C. (69)
Washington State (593)
West Virginia (3)
Wisconsin (65)
There are 845,154 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Startups
Etiome Steps Out of Stealth with $50M to Address Disease At The ‘Silent Stage’
With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in.
April 24, 2025
·
2 min read
·
Dan Samorodnitsky
Vaccines
After Missed Decision Deadline, Novavax Says COVID-19 Shot ‘Approvable’
The FDA is asking Novavax for a non-mandatory postmarketing commitment to produce additional clinical data for its investigational COVID-19 vaccine.
April 24, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Vanda Escalates Vendetta Against FDA, Blasts ‘Bureaucrats’ For Delaying Stomach Drug
The tradipitant saga stretches back to September 2024, when the FDA declined to approve Vanda’s drug in gastroparesis, a stomach condition characterized by delayed gastric emptying.
April 24, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Sales Of Merck’s 4-Way Measles Vaccine Take Hit as US Dips Into Stockpile
Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks. Sales of the vaccine were $539 million for the quarter, a 5% decline from the same period in 2024.
April 24, 2025
·
2 min read
·
Annalee Armstrong
Layoffs
Guessing Game: Former HHS Workers’ Next Stops Unclear
Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely aren’t the main destination. Two biopharma executives discuss potential landing spots.
April 24, 2025
·
5 min read
·
Angela Gabriel
Job Trends
Massive Investment in US Manufacturing Triggers Wave of Career Opportunities
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca executive and Eli Lilly and Novo Nordisk spokespeople discuss potential job and skill-building opportunities and where manufacturing might head in the future.
April 24, 2025
·
6 min read
·
Angela Gabriel
Tariffs
Roche in ‘Very, Very Good Position’ to Weather Trump Tariffs, But M&A May Suffer
Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., according to CEO Thomas Schinecker, who declined to reveal what these assets are.
April 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
LEM Surgical Announces FDA Clearance of Dynamis Robotic Surgical System
April 24, 2025
·
2 min read
Press Releases
West Announces Leadership Changes
April 24, 2025
·
4 min read
1 of 84,516
Next
